Dr Schulder is on our medical advisory board and one of my favorite brain tumor neurosurgeons.. he is doing a trial of rindopepimut (which used to be known as cdx-110). This is a vaccine against the Epidermal Growth Factor Receptor version 3(EGFRvIII) , which is a mutation of the EGFR which is found on normal cells. (The article is wrong on that point). If EGFRvIII is found on your tumor, it is a bad sign - the tumor is of the more aggressive variety because this receptor makes the tumor grow faster. This vaccine inactivates the EGFRvIII. The hope is that it can stop the tumor from growing, or even if it fails, it might be able to convert the tumor into a slower growing tumor with a better prognosis.
Best part is that it is relatively easy injections into the skin - not into the brain.
(Disclosure: the company that makes rindopepimut is a sponsor of our foundation, and Dr Schulder is on our medical advisory board)
